Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Christian Hurtz

Showing results (11-20 of 27) with videos related to

Pageof 3
Sort By:
The Journal of Clinical Investigation|March 20, 2020
Oncogene-independent BCR-like signaling adaptation confers drug resistance in Ph-like ALLChristian Hurtz, Gerald B Wertheim, Joseph P Loftus, et al.
Science Signaling|February 10, 2026
Dynamic feedback control of oncogenic tyrosine kinase signaling in acute leukemiaJaewoong Lee, Ruifeng Sun, Kohei Kume, et al.
The Journal of Experimental Medicine|September 14, 2011
BCL6-mediated repression of p53 is critical for leukemia stem cell survival in chronic myeloid leukemiaChristian Hurtz, Katerina Hatzi, Leandro Cerchietti, et al.
Blood|June 2, 2021
Activated natural killer cells predict poor clinical prognosis in high-risk B- and T-cell acute lymphoblastic leukemiaCaroline Duault, Anil Kumar, Adeleh Taghi Khani, et al.
Nature Medicine|July 16, 2013
BACH2 mediates negative selection and p53-dependent tumor suppression at the pre-B cell receptor checkpointSrividya Swaminathan, Chuanxin Huang, Huimin Geng, et al.
Cancer Cell|June 16, 2015
Erk Negative Feedback Control Enables Pre-B Cell Transformation and Represents a Therapeutic Target in Acute Lymphoblastic LeukemiaSeyedmehdi Shojaee, Rebecca Caeser, Maike Buchner, et al.
Leukemia|March 28, 2025
DYRK1A inhibition results in MYC and ERK activation rendering KMT2A-R acute lymphoblastic leukemia cells sensitive to BCL2 inhibitionV S S Abhinav Ayyadevara, Gerald Wertheim, Shikha Gaur, et al.
The Journal of Experimental Medicine|May 26, 2010
BCL6 is critical for the development of a diverse primary B cell repertoireCihangir Duy, J Jessica Yu, Rahul Nahar, et al.
Nature|May 20, 2011
BCL6 enables Ph+ acute lymphoblastic leukaemia cells to survive BCR-ABL1 kinase inhibitionCihangir Duy, Christian Hurtz, Seyedmehdi Shojaee, et al.
Molecular Systems Biology|February 17, 2017
Recurrent patterns of DNA copy number alterations in tumors reflect metabolic selection pressuresNicholas A Graham, Aspram Minasyan, Anastasia Lomova, et al.
Pageof 3

Showing results (11-20 of 27) with videos related to

Sort By:
Pageof 3
The Journal of Clinical Investigation|March 20, 2020
Oncogene-independent BCR-like signaling adaptation confers drug resistance in Ph-like ALLChristian Hurtz, Gerald B Wertheim, Joseph P Loftus, et al.
Science Signaling|February 10, 2026
Dynamic feedback control of oncogenic tyrosine kinase signaling in acute leukemiaJaewoong Lee, Ruifeng Sun, Kohei Kume, et al.
The Journal of Experimental Medicine|September 14, 2011
BCL6-mediated repression of p53 is critical for leukemia stem cell survival in chronic myeloid leukemiaChristian Hurtz, Katerina Hatzi, Leandro Cerchietti, et al.
Blood|June 2, 2021
Activated natural killer cells predict poor clinical prognosis in high-risk B- and T-cell acute lymphoblastic leukemiaCaroline Duault, Anil Kumar, Adeleh Taghi Khani, et al.
Nature Medicine|July 16, 2013
BACH2 mediates negative selection and p53-dependent tumor suppression at the pre-B cell receptor checkpointSrividya Swaminathan, Chuanxin Huang, Huimin Geng, et al.
Cancer Cell|June 16, 2015
Erk Negative Feedback Control Enables Pre-B Cell Transformation and Represents a Therapeutic Target in Acute Lymphoblastic LeukemiaSeyedmehdi Shojaee, Rebecca Caeser, Maike Buchner, et al.
Leukemia|March 28, 2025
DYRK1A inhibition results in MYC and ERK activation rendering KMT2A-R acute lymphoblastic leukemia cells sensitive to BCL2 inhibitionV S S Abhinav Ayyadevara, Gerald Wertheim, Shikha Gaur, et al.
The Journal of Experimental Medicine|May 26, 2010
BCL6 is critical for the development of a diverse primary B cell repertoireCihangir Duy, J Jessica Yu, Rahul Nahar, et al.
Nature|May 20, 2011
BCL6 enables Ph+ acute lymphoblastic leukaemia cells to survive BCR-ABL1 kinase inhibitionCihangir Duy, Christian Hurtz, Seyedmehdi Shojaee, et al.
Molecular Systems Biology|February 17, 2017
Recurrent patterns of DNA copy number alterations in tumors reflect metabolic selection pressuresNicholas A Graham, Aspram Minasyan, Anastasia Lomova, et al.
Pageof 3